Ordering Recommendation

Not recommended as a stand-alone test. Parvovirus B19 Antibodies, IgG and IgM is preferred (0065120).

Mnemonic
PARVO G
Methodology

Semi-Quantitative Enzyme-Linked Immunosorbent Assay

Performed

Sun-Sat

Reported

1-2 days

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect

Serum Separator Tube (SST).

Specimen Preparation

Separate from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to an ARUP Standard Transport Tube. (Min: 0.3 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens.

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Contaminated, heat-inactivated, hemolyzed, lipemic, or icteric specimens.

Remarks

Mark specimens plainly as "acute" or "convalescent."

Stability

After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)

Reference Interval

0.90 IV or less: Negative - No significant level of detectable Parvovirus B19 IgG antibody.
0.91-1.09 IV: Equivocal - Repeat testing in 7-21 days may be helpful.
1.10 IV or greater: Positive - IgG antibody to Parvovirus B19 detected, which may indicate a current or past infection.

Interpretive Data

The best evidence for current infection is a significant change on two appropriately timed specimens, where both tests are done in the same laboratory at the same time.

Compliance Category

FDA

Note
Hotline History
N/A
CPT Codes

86747

Components
Component Test Code* Component Chart Name LOINC
0065121 Parvovirus B19 Antibody IgG 5273-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • B19
  • B19 IgG Antibodies
  • Erythrovirus B19 IgG
  • Fifth Disease
  • Human Parvovirus B19 IgG
Parvovirus B19 Antibody, IgG